<DOC>
	<DOCNO>NCT00245479</DOCNO>
	<brief_summary>To evaluate overall response desmopressin treatment among previously untreated enuretic child age 5-15 year 3 6 month treatment . To investigate influence possible predictive factor response 3 6 month treatment . To evaluate proportion patient achieve dryness . To evaluate long-term safety profile oral desmopressin child primary nocturnal enuresis .</brief_summary>
	<brief_title>A Study Oral Desmopressin Previously Untreated Children Aged 5 15 Years With Primary Nocturnal Enuresis</brief_title>
	<detailed_description>To evaluate overall response desmopressin treatment among previously untreated enuretic child age 5-15 year 3 6 month treatment . To investigate influence possible predictive factor response 3 6 month treatment . To evaluate proportion patient achieve dryness . To evaluate long-term safety profile oral desmopressin child primary nocturnal enuresis .</detailed_description>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Nocturnal Enuresis</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Inclusion criterion : Children suffer primary nocturnal enuresis organic pathology . Children either sex , 5 15 year age ( 6 year The Netherlands France ) . Children minimum 6 wet night 2 week . Exclusion criterion : Children previously treat desmopressin medication nocturnal enuresis enuresis alarm . Children receive substance know suspected potentiate antidiuretic hormone , e.g . SSRI , tricyclic antidepressant drug , chlorpromazine carbamazepine . Diagnosed renal diabetes insipidus central diabetes insipidus AVP ( arginine vasopressin ) deficiency . Proven urinary tract infection within past month document positive urine culture start study</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Primary nocturnal enuresis</keyword>
</DOC>